Mice treated with an isotype control progressed to develop severe arthritis, while therapeutic injections of anti-GM-CSF starting from day 9 during ~3 weeks either stabilized or reduced the clinical score of arthritis (Fig. 3i). Here, CSF2 is linked to arthritic joint disease.